RGC
Regencell Bioscience Holding
NASDAQ · Pharmaceuticals
$27.23
+2.16 (+8.62%)
Performance
1D
—
1W
-3.71%
1M
-38.27%
3M
+87.28%
6M
+102.91%
1Y
+27,600.92%
YTD
+32.57%
Open$26.67
Previous Close$25.07
Day High$28.83
Day Low$26.10
52W High$83.60
52W Low$0.09
Volume118.4K
Avg Volume282.4K
Market Cap13.46B
P/E Ratio—
EPS$-0.01
SectorPharmaceuticals
Volume Analysis
0.42x average volume
Technical Indicators
SMA 50
$24.38
Above
SMA 200
$17.43
Above
RSI (14)
49.7
Neutral
Trend
Golden Cross
Bullish
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.66B | 3.76B | 3.59B |
| Net Income | 706.46M | 788.49M | 815.65M |
| Profit Margin | 19.3% | 21.0% | 22.7% |
| EBITDA | 1.06B | 1.04B | 1.04B |
| Free Cash Flow | 809.03M | 638.27M | 648.55M |
| Rev Growth | +1.6% | +15.1% | +20.8% |
| Debt/Equity | 0.23 | 0.28 | 0.31 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |